-
My Account
In App
My Account
BSE Live
Nov 26, 16:01Prev. Close
1464.75
Open Price
1443.55
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 26, 15:50Prev. Close
1465.10
Open Price
1460.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1451.50 (240)
| Cash Flow of Tatva Chintan Pharma Chem (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 0.46 | 42.27 | 38.83 | 103.27 | 59.35 | |
| Net CashFlow From Operating Activities | 23.91 | 102.78 | 23.73 | 19.89 | 22.75 | |
| Net Cash Used In Investing Activities | -65.25 | -120.54 | -101.12 | -196.81 | -20.40 | |
| Net Cash Used From Financing Activities | 16.57 | 30.54 | 37.82 | 234.96 | -8.59 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.02 | -0.01 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -24.78 | 12.80 | -39.59 | 58.05 | -6.23 | |
| Cash And Cash Equivalents Begin of Year | 33.99 | 21.19 | 60.78 | 2.73 | 9.82 | |
| Cash And Cash Equivalents End Of Year | 9.21 | 33.99 | 21.19 | 60.78 | 3.59 |
24.11.2025
Reduce Tatva Chintan Pharma Chem; target of Rs 1380: Deven Choksey
10.11.2025
Tatva Chintan Standalone September 2025 Net Sales at Rs 115.86 crore, up 43.11% Y-o-Y
31.10.2025
Tatva Chintan Consolidated September 2025 Net Sales at Rs 123.52 crore, up 47.94% Y-o-Y
03.09.2025
Sell Tatva Chintan Pharma Chem; target of Rs 860: Deven Choksey
10.11.2025
Tatva Chintan Standalone September 2025 Net Sales at Rs 115.86 crore, up 43.11% Y-o-Y
31.10.2025
Tatva Chintan Consolidated September 2025 Net Sales at Rs 123.52 crore, up 47.94% Y-o-Y
25.07.2025
Tatva Chintan Consolidated June 2025 Net Sales at Rs 116.86 crore, up 10.81% Y-o-Y
25.07.2025
Tatva Chintan Standalone June 2025 Net Sales at Rs 109.18 crore, up 16.39% Y-o-Y
